Gene therapy to prevent reactions to allergens
US10293059B2 · kind B2 · utility
0Cited by
13References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 11, 2016 |
| Grant date | May 21, 2019 |
| Priority date | — |
| Expiry date | Apr 11, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2750/14143
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention is directed to a vector which comprises a promoter operably linked to a nucleic acid sequence encoding a therapeutic gene that blocks allergic reactions. The invention is also directed to a composition comprising the vector and method of using the vector to reduce or inhibit an immune response or allergic reaction to an allergen in a mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.